No human clinical trials have specifically evaluated isolated cinchonine as a therapeutic agent or dietary supplement, leaving its clinical evidence base essentially nonexistent. Historical use of cinchona bark preparations — which contain cinchonine alongside quinine, quinidine, and cinchonidine — provided empirical support for antimalarial activity, but attributing outcomes to cinchonine alone is not possible from this data. In vitro studies demonstrate measurable P-glycoprotein inhibition and antiparasitic activity at micromolar concentrations, but these findings have not been translated into controlled human trials. The overall evidence strength is preclinical only, and cinchonine cannot be recommended for any therapeutic indication based on current research.
Origin
Cinchonine is a naturally occurring alkaloid found in the bark of Cinchona species, particularly Cinchona micrantha, native to South America. It is extracted through isolation processes from cinchona bark and appears as white or faintly yellow crystalline powder with the molecular formula C₁₉H₂₂N₂O.
Potential benefits
• No clinically proven health benefits - no human clinical trials identified in available research • Historically associated with cinchona bark's antimalarial properties, though specific benefits of isolated cinchonine not established • Used primarily in chemical synthesis rather than as a therapeutic agent • Light-sensitive compound requiring special storage conditions • No evidence-based therapeutic applications documented
How it works
Cinchonine inhibits the formation of hemozoin (malaria pigment) by interfering with heme polymerization in Plasmodium falciparum, preventing the parasite from detoxifying toxic free heme. It also acts as a potent inhibitor of P-glycoprotein (P-gp, ABCB1), a membrane efflux transporter, which has raised interest in reversing multidrug resistance in cancer cells. Additionally, cinchonine has demonstrated inhibition of cytochrome P450 enzymes, particularly CYP2D6 and CYP3A4, affecting metabolism of multiple co-administered drugs.
What the research says
No key human clinical trials, RCTs, or meta-analyses were identified for cinchonine as a primary therapeutic agent. The available sources note its occurrence in cinchona bark alongside quinine but do not reference specific clinical studies or PubMed PMIDs for cinchonine itself.
Safety and interactions
Cinchonine shares structural and pharmacological similarities with quinine and quinidine, raising concern for cinchonism — a syndrome involving tinnitus, headache, nausea, and visual disturbances at elevated doses. Its inhibition of CYP2D6 and CYP3A4 creates significant potential for drug-drug interactions, particularly with anticoagulants, antiarrhythmics, and drugs with narrow therapeutic windows. Cinchona alkaloids as a class are contraindicated in pregnancy due to documented uterine stimulant effects and potential teratogenicity observed in animal models. Individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency face heightened risk of hemolytic anemia from cinchona-derived alkaloids.
Suggested use
No clinically studied dosage ranges or standardization details are available, as no human clinical data has been reported. Consult a healthcare provider before starting any new supplement.
Frequently asked questions
Is cinchonine the same as quinine?
Cinchonine and quinine are both cinchona alkaloids but are distinct compounds. Quinine contains a methoxy group (-OCH3) on its quinoline ring that cinchonine lacks, making cinchonine its desmethoxy analog. This structural difference results in somewhat different pharmacological potency and metabolic profiles, though both inhibit heme polymerization in malaria parasites.
Can cinchonine reverse drug resistance in cancer?
In vitro studies have shown cinchonine inhibits P-glycoprotein (P-gp/ABCB1), an efflux pump responsible for multidrug resistance in cancer cells, at concentrations in the low micromolar range. Laboratory experiments demonstrated enhanced intracellular accumulation of chemotherapy agents like doxorubicin in resistant cell lines when cinchonine was co-applied. However, no human clinical trials have evaluated this effect, so no conclusions about cancer treatment efficacy can be drawn.
What foods or plants naturally contain cinchonine?
Cinchonine is found naturally in the bark of Cinchona tree species, particularly Cinchona officinalis and Cinchona pubescens, native to South America. The bark typically contains a mixture of alkaloids including quinine, quinidine, cinchonidine, and cinchonine, with concentrations varying by species and growing conditions. Cinchonine is not meaningfully present in common dietary foods.
Is cinchonine safe to take as a supplement?
Cinchonine is not established as a safe or approved dietary supplement, and no standardized dosing guidelines exist for human use. Its structural similarity to quinine means it carries risk of cinchonism symptoms — including tinnitus, nausea, and cardiac arrhythmias at high doses — and it inhibits CYP2D6 and CYP3A4 enzymes, creating drug interaction potential. Anyone considering cinchona alkaloid products should consult a physician, particularly those on medications with narrow therapeutic windows.
How does cinchonine differ from cinchonidine?
Cinchonine and cinchonidine are stereoisomers — they share the same molecular formula (C19H22N2O) and connectivity but differ in the spatial configuration at their chiral centers (C8 and C9). Cinchonidine is the 8S,9R enantiomeric pair corresponding to cinchonine's 8R,9S configuration. These stereochemical differences produce distinct interactions with biological targets, and cinchonidine is generally considered to have greater antimalarial potency than cinchonine in comparative in vitro studies.
What is the current research status on cinchonine's therapeutic potential?
Cinchonine has not undergone human clinical trials and lacks clinically proven health benefits in evidence-based medicine. While historically associated with cinchona bark's antimalarial properties, the specific therapeutic effects of isolated cinchonine have not been established through rigorous research. Most scientific interest in cinchonine focuses on its use as a chemical reagent in synthesis rather than as a therapeutic agent.
References
This article is educational and is not medical advice. Statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before use.
